Company intelligence
Betthera
Regulatory affairs and economic and social impact of medical technologies
About Betthera
Betthera provides detailed assessments of economic and social impact and enables qualified decision making for development and implementation of medical and emerging technologies. In Regulatory Affairs, Betthera implements an effective quality management system (QMS) meeting the regulatory requirements in the field of medical devices.
Verified activity
Signals from Betthera
6 published signals
Research & Knowledge
Betthera is closing its 16-part Medical Device Essentials summer series.
Reported by Betthera
People
Betthera Regulatory Analyst Pavel Kušnierik focused his efforts on three specific behavioral changes to humanize regulatory affairs, including listening, specificity, and patience.
Reported by Pavel Kušnierik
Presence & Recognition
Betthera is attending the Warsaw Medical Expo, Prague.bio Conference 2026, Building Strong Networks in Cluster 1 Health & Mission Cancer – Brokerage Event, and MEDICA 2026 events in September 2026.
Reported by Betthera
People
Betthera welcomed Pavel Kušnierik as a Regulatory Analyst over a year prior.
Reported by Pavel Kušnierik
Presence & Recognition
Betthera Regulatory Analyst Pavel Kušnierik will be actively walking through Halls B and D at Warsaw Medical Expo 2026 on September 16 and 17 to share experiences and tackle regulatory roadblocks.
Reported by Pavel Kušnierik
Presence & Recognition
Betthera team will be attending Prague.bio Conference in Prague on 23 September 2026.
Reported by Betthera